We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

UCB (Pharma) Ireland Limited

United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin 24, Ireland
Telephone: + 353 14637395
Medical Information Direct Line: +353 1 463 2371
Medical Information e-mail: UCBCares.IE@ucb.com
Patient Information Leaflet last updated on medicines.ie: 13/11/2017
PIL Xyzal 5mg/ml oral drops, solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 13/11/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
Updated on 11/01/2017 and displayed until 13/11/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 25/05/2016 and displayed until 11/01/2017
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
  • Change of special precautions for disposal
  • Addition of information on reporting a side effect.
Updated on 19/09/2012 and displayed until 25/05/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 21/03/2012 and displayed until 19/09/2012
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to side-effects
Updated on 08/10/2010 and displayed until 21/03/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to instructions about missed dose
  • Change to side-effects
  • Change to information about driving or using machinery
Updated on 01/10/2009 and displayed until 08/10/2010
Reasons for adding or updating:
  • Change to improve clarity and readability
Updated on 02/11/2007 and displayed until 01/10/2009
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 14/07/2006 and displayed until 02/11/2007
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Levocetirizine dihydrochloride